Clearance of longstanding treatment-resistant warts during COVID-19 in a transplant recipient.

Erkayman, Merve H; Bilen, Handan

Erkayman, Merve H; Bilen, Handan.

Erkayman MH; Department of Dermatology, Faculty of Medicine, Atatürk University, Erzurum, Turkey.
Bilen H; Department of Dermatology, Faculty of Medicine, Atatürk University, Erzurum, Turkey.

Transpl Infect Dis ; 23(4): e13572, 2021 Aug.

Article in English | MEDLINE | ID: covidwho-1052295

ABSTRACT

ABSTRACT

Human papillomavirus (HPV), a DNA virus, infects basal keratinocytes and causes common warts and as well as malignancies of skin and mucous membranes. Although many treatment options are available, persistent HPV infections are common among transplant recipients. Herein, we present a patient with a 15-year history of treatment-resistant warts that regressed during COVID-19 (Coronavirus disease 2019) treatment.

Subject(s)

COVID-19; Papillomavirus Infections; Warts; Humans; Papillomaviridae; Papillomavirus Infections/drug therapy; SARS-CoV-2; Transplant Recipients; Warts/drug therapy

Keywords

COVID-19; favipiravir; human papillomavirus; solid organ transplant; warts

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Warts / Papillomavirus Infections / COVID-19 Type of study: Case report / Prognostic study Limits: Humans Language: English Journal: Transpl Infect Dis Journal subject: Transplantation Year: 2021 Document Type: Article Affiliation country: Tid.13572

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google